Urethral Stenting for Transitional Cell Carcinoma
All procedures are performed by
Dr. Joe Bartges, DVM, PhD, DACVIM, DACVN
Transitional Cell Carcinoma is a cancer of the urinary bladder. It is a disease in which tumor grows within the urinary bladder and urethra (the tube leading from the bladder to the outside of the body). The location in which it grows makes it very difficult to remove surgically. The tumor eventually grows, occluding the urethra, making it impossible for your pet to urinate. When your pet loses its ability to urinate, death is inevitable unless the obstruction is relieved. Here at the University of Tennessee we are able to help prolong your petís survival time by placing a urethral stent. The self-expanding metal stents are used to keep the urethra open, improving their quality and quantity of life in conjunction with medical treatment.
During this procedure we use fluoroscopy. Fluoroscopy is a radiologic technique that allows us to visualize internal structures in real time using a Fluoroscope. Once the area of obstruction is identified we are able pass a stent through the urethra and place it in the appropriate spot. This procedure effectively pushes the obstructing tissue out of the way letting urine pass.
Because of urethral stenting we are able to offer animals with Transitional Cell Carcinoma a longer, more comfortable life. The procedure is performed under general anesthesia, but is minimally invasive with no need for surgical incisions. Recovery from the stenting is quick and the procedure is fast, safe and effective. Most animals experience urinary incontinence for 5-7 days after the procedure, but over 85% of them become continent or have improvement.
If you are interested in finding out more about urethral stenting or you would like to make an appointment, please contact Amanda Callens.